Stage IV kidney cancer patient miraculously comes back from hospice
Follow
After receiving two doses of an immunotherapy agent and stereotactic radiation, 73yearold Harold Wellbaum saw remarkable improvements in his cancer and his strength. The concept is now being explored in a clinical trial at UT Southwestern.